Clinical Trials Browser

Interventional × Bone Neoplasms × pembrolizumab × Clear all

NCT04616248 2026-01-07

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

Phase 1 Active not recruiting

BreastDermatologicSarcoma

Bone Neoplasms, Breast Neoplasms, Carcinoma, Basal Cell, Melanoma, Sarcoma, Osteosarcoma, Carcinoma, Merkel Cell

NCT02301039 2020-09-29

SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas

Phase 2 Completed

144 enrolled 16 charts

Bone Neoplasms, Sarcoma

NCT02303366 2017-10-18

BOSTON II

Phase 1 Completed

Bone Neoplasms, Breast Neoplasms